Effectiveness of omeprazol, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer.: Preliminary results of GEHPY study

被引:5
作者
Baños, F
Madridejos, R
Cabezas, C
Burrull, M
Lafuente, C
Morera, R
机构
[1] Hosp Llobregat, Consorci Hosp Creu Roja, Barcelona, Spain
[2] Inst Catala Salut, Direcc Atenc Primeria Hosp Llobregat, Barcelona, Spain
[3] Inst Catala Salut, Direcc Atenc Primaria Baix Llobregat Ctr, Barcelona, Spain
来源
MEDICINA CLINICA | 2000年 / 114卷 / 12期
关键词
Helicobacter pylori; peptic ulcer; randomised controlled trial;
D O I
10.1016/S0025-7753(00)71326-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: TO compare the effectiveness of two length of the same therapy to eradicate Helicobacter pylori in patients with non complicated active peptic ulcer. PATIENTS AND METHODS: 223 patients visited at primary health centres. A randomised controlled trial was carried out to compare the results of 6 or 7 days of treatment with chlaritromicyn 500 mg, amoxicillin 1 g and omeprazole 20 mg, b.i.d. All patients received omeprazole for other 14 days. RESULTS: 108 patients were randomised to the 6 days group and 115 to the 7 days one. Both groups were comparable with respect to basic characteristics except for sex: the proportion of men was higher in the 6 days group (p = 0.04). 91.4% of the patients received all the treatment correctly. By intention to treat analysis, eradication rates were 76.9% in the 6 days group and 77.4% in the seven days group (IC 95% of the difference from -10.5 to 11.6). There were not statistically significant differences in eradication rates in relation to age, sex, ulcer location, recurrence or tobacco consumption. CONCLUSIONS: Although eradication rates are lower than expected, in this study there are no differences between 6 or 7 days of therapy.
引用
收藏
页码:441 / 443
页数:3
相关论文
共 10 条
[1]  
BREA ML, 1997, J ANTIMICROB CHEMOTH, V40, P279
[2]  
Garcia-Romero E, 1999, Gastroenterol Hepatol, V22, P1
[3]  
Gisbert JP, 1997, MED CLIN-BARCELONA, V108, P524
[4]  
Huelin Benitez J., 1997, Gut, V41, pA105
[5]  
Malfertheiner P, 1997, GUT, V41, P8
[6]  
Mota AP, 1997, REV ESP ENFERM DIG, V89, P882
[7]  
Rodrigo Saez L., 1997, Revista Espanola de Enfermedades Digestivas, V89, P146
[8]  
Sanfelix Genoves J, 1998, Aten Primaria, V21, P517
[9]   THE TREATMENT OF HELICOBACTER-PYLORI INFECTION IN THE MANAGEMENT OF PEPTIC-ULCER DISEASE [J].
WALSH, JH ;
PETERSON, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (15) :984-991
[10]  
WARREN JR, 1983, LANCET, V1, P1273